Andlauer Healthcare Group Inc.
Andlauer Healthcare Group Inc. Fundamental Analysis
Andlauer Healthcare Group Inc. (ANDHF) shows weak financial fundamentals with a PE ratio of 40.71, profit margin of 10.43%, and ROE of 11.68%. The company generates $0.5B in annual revenue with weak year-over-year growth of 0.39%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 45.4/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze ANDHF's fundamental strength across five key dimensions:
Efficiency Score
WeakANDHF struggles to generate sufficient returns from assets.
Valuation Score
ModerateANDHF shows balanced valuation metrics.
Growth Score
WeakANDHF faces weak or negative growth trends.
Financial Health Score
ExcellentANDHF maintains a strong and stable balance sheet.
Profitability Score
WeakANDHF struggles to sustain strong margins.
Key Financial Metrics
Is ANDHF Expensive or Cheap?
P/E Ratio
ANDHF trades at 40.71 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, ANDHF's PEG of -12.75 indicates potential undervaluation.
Price to Book
The market values Andlauer Healthcare Group Inc. at 4.74 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 15.30 times EBITDA. This signals the market has high growth expectations.
How Well Does ANDHF Make Money?
Net Profit Margin
For every $100 in sales, Andlauer Healthcare Group Inc. keeps $10.43 as profit after all expenses.
Operating Margin
Core operations generate 13.68 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $11.68 in profit for every $100 of shareholder equity.
ROA
Andlauer Healthcare Group Inc. generates $7.44 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Andlauer Healthcare Group Inc. produces operating cash flow of $91.00M, showing steady but balanced cash generation.
Free Cash Flow
Andlauer Healthcare Group Inc. generates strong free cash flow of $73.35M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $1.87 in free cash annually.
FCF Yield
ANDHF converts 3.57% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
40.71
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-12.75
vs 25 benchmark
P/B Ratio
Price to book value ratio
4.74
vs 25 benchmark
P/S Ratio
Price to sales ratio
4.22
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.41
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.35
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.12
vs 25 benchmark
ROA
Return on assets percentage
0.07
vs 25 benchmark
ROCE
Return on capital employed
0.12
vs 25 benchmark
How ANDHF Stacks Against Its Sector Peers
| Metric | ANDHF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 40.71 | 25.81 | Worse (Expensive) |
| ROE | 11.68% | 1255.00% | Weak |
| Net Margin | 10.43% | -46749.00% (disorted) | Strong |
| Debt/Equity | 0.41 | 0.78 | Strong (Low Leverage) |
| Current Ratio | 1.35 | 10.04 | Neutral |
| ROA | 7.44% | -1492798.00% (disorted) | Weak |
ANDHF outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Andlauer Healthcare Group Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
109.40%
Industry Style: Cyclical, Value, Infrastructure
High GrowthEPS CAGR
102.14%
Industry Style: Cyclical, Value, Infrastructure
High GrowthFCF CAGR
90.38%
Industry Style: Cyclical, Value, Infrastructure
High Growth